Provided by Tiger Trade Technology Pte. Ltd.

Amphastar Pharmaceuticals

19.56
+0.06000.31%
Volume:245.47K
Turnover:4.82M
Market Cap:887.44M
PE:9.64
High:20.08
Open:20.06
Low:19.38
Close:19.50
52wk High:31.26
52wk Low:17.03
Shares:45.37M
Float Shares:34.22M
Volume Ratio:0.41
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.03
EPS(LYR):2.03
ROE:12.90%
ROA:6.37%
PB:1.13
PE(LYR):9.64

Loading ...

BRIEF-Amphastar Pharmaceuticals Inc - Authorizes $50 Million Increase To Share Buyback Program On March 12, 2026 - SEC Filing

Reuters
·
Mar 16

Amphastar Pharmaceuticals Inc - Authorizes $50 Mln Increase to Share Buyback Program on March 12, 2026 - SEC Filing

THOMSON REUTERS
·
Mar 16

Amphastar Pharmaceuticals publishes investor presentation outlining shift to proprietary and biosimilar drug pipeline mix at 85%

Reuters
·
Mar 11

BRIEF-Amphastar Pharmaceuticals- Nanjing Pharmaceuticals Enters Supply Agreement With Nanjing Letop Biotechnology On March 3 - SEC Filing

Reuters
·
Mar 07

Amphastar Pharmaceuticals: on March 3, Co & Nanjing Hanxin Pharmaceutical Technology Entered Into Amendment to Contract Research Agreement

THOMSON REUTERS
·
Mar 07

Amphastar Pharmaceuticals Inc - Supply Agreement Effective for Five Years With Payments in Chinese Yuan - SEC Filing

THOMSON REUTERS
·
Mar 07

Amphastar Pharmaceuticals: Pursuant to Amendment, Co to Use Research Cell Banks That Hanxin Develops to Make Master Cell Banks for AMP-105

THOMSON REUTERS
·
Mar 07

Amphastar Signs New Executive Employment Agreements With Liawatidewi and Zhou

Reuters
·
Mar 07

Amphastar Nanjing Signs Five-Year Supply Agreement With Nanjing Letop Biotechnology

Reuters
·
Mar 07

Amphastar Pharmaceuticals Balances Growth Plans With Margin Risks

TIPRANKS
·
Mar 06

Amphastar Pharmaceuticals (AMPH) Margin Compression Reinforces Bearish Narratives Despite Low 9.5x P/E

Simply Wall St.
·
Feb 28

Amphastar Pharmaceuticals Down Nearly 16%, on Pace for Largest Percent Decrease Since June 2022 -- Data Talk

Dow Jones
·
Feb 28

Stock Track | Amphastar Pharmaceuticals Plummets 15.29% Intraday on Earnings Miss and Analyst Target Price Cut

Stock Track
·
Feb 27

Stock Track | Amphastar Pharmaceuticals Plunges 14.68% in Pre-Market on Earnings Miss and Analyst Target Price Cut

Stock Track
·
Feb 27

Amphastar Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
Feb 27

U.S. RESEARCH ROUNDUP-Cars.Com, Dell, Zscaler

Reuters
·
Feb 27

Stock Track | Amphastar Pharmaceuticals Plunges 6.87% Post-Market on Q4 Earnings and Revenue Miss

Stock Track
·
Feb 27

Amphastar Q4 revenue misses estimates

Reuters
·
Feb 27

Stock Track | Amphastar Pharmaceuticals Plunges 16.19% After-Hours on Q4 Earnings and Revenue Miss

Stock Track
·
Feb 27

Amphastar posts FY 2025 BAQSIMI sales of USD 185.4 million (+46%)

Reuters
·
Feb 27